Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free RVP Stock Alerts

Retractable Technologies (RVP) Competitors

Retractable Technologies logo
$0.68 0.00 (0.00%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$0.68 0.00 (0.00%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

RVP vs. SPAI, OM, NNOX, PYPD, and LNSR

Should you buy Retractable Technologies stock or one of its competitors? MarketBeat compares Retractable Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Retractable Technologies include Safe Pro Group (SPAI), Outset Medical (OM), Nano-X Imaging (NNOX), PolyPid (PYPD), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry.

How does Retractable Technologies compare to Safe Pro Group?

Safe Pro Group (NASDAQ:SPAI) and Retractable Technologies (NYSE:RVP) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

Retractable Technologies has a net margin of -41.11% compared to Safe Pro Group's net margin of -800.91%. Retractable Technologies' return on equity of -17.15% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Safe Pro Group-800.91% -119.17% -107.17%
Retractable Technologies -41.11%-17.15%-9.33%

Safe Pro Group presently has a consensus price target of $11.00, indicating a potential upside of 202.20%. Given Safe Pro Group's stronger consensus rating and higher possible upside, analysts plainly believe Safe Pro Group is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Safe Pro Group had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 1 mentions for Safe Pro Group and 0 mentions for Retractable Technologies. Safe Pro Group's average media sentiment score of 0.95 beat Retractable Technologies' score of 0.00 indicating that Safe Pro Group is being referred to more favorably in the media.

Company Overall Sentiment
Safe Pro Group Positive
Retractable Technologies Neutral

Safe Pro Group has a beta of 3.52, indicating that its share price is 252% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

7.6% of Retractable Technologies shares are owned by institutional investors. 54.8% of Safe Pro Group shares are owned by company insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Retractable Technologies has higher revenue and earnings than Safe Pro Group. Safe Pro Group is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safe Pro Group$610K124.66-$14.32M-$0.71N/A
Retractable Technologies$37.15M0.55-$7.01M-$0.21N/A

Summary

Retractable Technologies beats Safe Pro Group on 9 of the 17 factors compared between the two stocks.

How does Retractable Technologies compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

Retractable Technologies has lower revenue, but higher earnings than Outset Medical. Retractable Technologies is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$117.59M0.64-$81.65M-$4.16N/A
Retractable Technologies$37.15M0.55-$7.01M-$0.21N/A

Retractable Technologies has a net margin of -41.11% compared to Outset Medical's net margin of -63.65%. Retractable Technologies' return on equity of -17.15% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-63.65% -56.13% -27.45%
Retractable Technologies -41.11%-17.15%-9.33%

Outset Medical has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

In the previous week, Outset Medical had 4 more articles in the media than Retractable Technologies. MarketBeat recorded 4 mentions for Outset Medical and 0 mentions for Retractable Technologies. Outset Medical's average media sentiment score of 1.34 beat Retractable Technologies' score of 0.00 indicating that Outset Medical is being referred to more favorably in the media.

Company Overall Sentiment
Outset Medical Positive
Retractable Technologies Neutral

7.6% of Retractable Technologies shares are held by institutional investors. 2.5% of Outset Medical shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Outset Medical currently has a consensus target price of $10.00, suggesting a potential upside of 147.52%. Given Outset Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Outset Medical is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Outset Medical beats Retractable Technologies on 9 of the 16 factors compared between the two stocks.

How does Retractable Technologies compare to Nano-X Imaging?

Retractable Technologies (NYSE:RVP) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

Retractable Technologies has higher revenue and earnings than Nano-X Imaging. Retractable Technologies is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$37.15M0.55-$7.01M-$0.21N/A
Nano-X Imaging$14.52M4.30-$75.02M-$1.58N/A

Retractable Technologies has a net margin of -41.11% compared to Nano-X Imaging's net margin of -716.44%. Retractable Technologies' return on equity of -17.15% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
Nano-X Imaging -716.44%-70.96%-62.26%

Retractable Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

In the previous week, Nano-X Imaging had 21 more articles in the media than Retractable Technologies. MarketBeat recorded 21 mentions for Nano-X Imaging and 0 mentions for Retractable Technologies. Nano-X Imaging's average media sentiment score of 0.07 beat Retractable Technologies' score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company Overall Sentiment
Retractable Technologies Neutral
Nano-X Imaging Neutral

Nano-X Imaging has a consensus price target of $4.00, suggesting a potential upside of 346.33%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Nano-X Imaging beats Retractable Technologies on 10 of the 17 factors compared between the two stocks.

How does Retractable Technologies compare to PolyPid?

Retractable Technologies (NYSE:RVP) and PolyPid (NASDAQ:PYPD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

In the previous week, PolyPid had 21 more articles in the media than Retractable Technologies. MarketBeat recorded 21 mentions for PolyPid and 0 mentions for Retractable Technologies. PolyPid's average media sentiment score of 0.24 beat Retractable Technologies' score of 0.00 indicating that PolyPid is being referred to more favorably in the news media.

Company Overall Sentiment
Retractable Technologies Neutral
PolyPid Neutral

Retractable Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market. Comparatively, PolyPid has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

Retractable Technologies has higher revenue and earnings than PolyPid. Retractable Technologies is trading at a lower price-to-earnings ratio than PolyPid, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$37.15M0.55-$7.01M-$0.21N/A
PolyPidN/AN/A-$34.17M-$1.91N/A

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 26.5% of PolyPid shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 24.7% of PolyPid shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PolyPid has a consensus target price of $11.33, suggesting a potential upside of 190.60%. Given PolyPid's stronger consensus rating and higher possible upside, analysts clearly believe PolyPid is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
PolyPid
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

PolyPid has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat PolyPid's return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
PolyPid N/A -241.96%-126.91%

Summary

PolyPid beats Retractable Technologies on 8 of the 15 factors compared between the two stocks.

How does Retractable Technologies compare to LENSAR?

LENSAR (NASDAQ:LNSR) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

Retractable Technologies has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LENSAR$57.70M1.19-$34.28M-$0.58N/A
Retractable Technologies$37.15M0.55-$7.01M-$0.21N/A

LENSAR has a net margin of 50.94% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
LENSAR50.94% -183.19% 42.26%
Retractable Technologies -41.11%-17.15%-9.33%

In the previous week, LENSAR had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for LENSAR and 0 mentions for Retractable Technologies. LENSAR's average media sentiment score of 0.93 beat Retractable Technologies' score of 0.00 indicating that LENSAR is being referred to more favorably in the media.

Company Overall Sentiment
LENSAR Positive
Retractable Technologies Neutral

LENSAR currently has a consensus price target of $10.00, suggesting a potential upside of 78.57%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts plainly believe LENSAR is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

40.2% of LENSAR shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 65.8% of LENSAR shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

LENSAR has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market.

Summary

LENSAR beats Retractable Technologies on 11 of the 16 factors compared between the two stocks.

Get Retractable Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVP vs. The Competition

Export
MetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$20.36M$41.50M$6.87B$23.47B
Dividend YieldN/A1.08%2.67%4.20%
P/E Ratio-1.2617.8327.1430.75
Price / Sales0.5528.68517.06166.31
Price / Cash48.2518.8650.5431.69
Price / Book0.218.4910.284.73
Net Income-$7.01M-$16.99M$3.60B$1.07B
7 Day Performance-0.66%-4.36%-1.27%-0.45%
1 Month Performance-2.19%-2.71%-0.37%0.72%
1 Year Performance-3.83%-19.38%18.30%14.09%

Retractable Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVP
Retractable Technologies
N/A$0.68
flat		N/A-3.6%$20.36M$37.15MN/A240
SPAI
Safe Pro Group
3.198 of 5 stars		$3.78
-1.3%		$11.00
+191.0%		-3.2%$79.99M$1.64MN/A11
OM
Outset Medical
3.5352 of 5 stars		$4.13
+0.2%		$10.00
+142.1%		-77.1%$76.37M$119.48MN/A520
NNOX
Nano-X Imaging
2.643 of 5 stars		$0.98
-9.4%		$4.00
+308.6%		-82.8%$75.16M$13.02MN/A190
PYPD
PolyPid
2.4599 of 5 stars		$4.00
+7.0%		$11.33
+183.3%		+4.3%$71.37MN/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:RVP) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel